PDT Partners’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.5M	Sell	116,641 -4,900	-4%	-$62.4K	0.09%	282
2025 Q4	$1.09M	Sell	121,541 -35,263	-22%	-$485K	0.07%	341
2025 Q3	$2.71M	Sell	156,804 -39,746	-20%	-$490K	0.17%	203
2025 Q2	$1.84M	Sell	196,550 -263,696	-57%	-$2.17M	0.1%	318
2025 Q1	$3.27M	Buy	460,246 +132,638	+40%	+$1.34M	0.23%	141
2024 Q4	$3.82M	Buy	327,608 +312,794	+2,111%	+$4.88M	0.34%	83
2024 Q3	$304K	Sell	14,814 -212,406	-93%	-$4.9M	0.03%	602
2024 Q2	$5.09M	Buy	227,220 +4,249	+2%	+$101K	0.48%	27
2024 Q1	$6.13M	Buy	222,971 +61,974	+38%	+$1.72M	0.58%	18
2023 Q4	$4.91M	Buy	160,997 +123,920	+334%	+$3.56M	0.54%	28
2023 Q3	$1.17M	Buy	+37,077	New	+$1.44M	0.15%	243
2021 Q4	–	Sell	-24,300	Closed	-$3.26M	–	970
2021 Q3	$3.26M	Sell	24,300 -26,900	-53%	-$4.07M	0.23%	192
2021 Q2	$8.29M	Sell	51,200 -2,737	-5%	-$213K	0.55%	4
2021 Q1	$4.33M	Sell	53,937 -36,463	-40%	-$2.45M	0.31%	107
2020 Q4	$4.92M	Buy	90,400 +6,891	+8%	+$250K	0.33%	127
2020 Q3	$1.66M	Sell	83,509 -18,634	-18%	-$389K	0.11%	235
2020 Q2	$2.15M	Sell	102,143 -957	-0.9%	-$16.3K	0.15%	206
2020 Q1	$1.26M	Buy	103,100 +17,583	+21%	+$237K	0.1%	202
2019 Q4	$1.25M	Buy	85,517 +27,317	+47%	+$380K	0.08%	245
2019 Q3	$777K	Sell	58,200 -88	-0.2%	-$1.4K	0.05%	297
2019 Q2	$954K	Buy	+58,288	New	+$916K	0.06%	258
2019 Q1	–	Sell	-87,743	Closed	-$1.2M	–	481
2018 Q4	$1.2M	Buy	87,743 +17	+0%	+$316	0.07%	255
2018 Q3	$2.51M	Sell	87,726 -18,783	-18%	-$546K	0.1%	213
2018 Q2	$2.91M	Sell	106,509 -8,745	-8%	-$212K	0.11%	209
2018 Q1	$2.43M	Buy	+115,254	New	+$2.83M	0.08%	248